266 related articles for article (PubMed ID: 23974695)
1. Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth.
Büll C; Boltje TJ; Wassink M; de Graaf AM; van Delft FL; den Brok MH; Adema GJ
Mol Cancer Ther; 2013 Oct; 12(10):1935-46. PubMed ID: 23974695
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread.
Büll C; Boltje TJ; van Dinther EA; Peters T; de Graaf AM; Leusen JH; Kreutz M; Figdor CG; den Brok MH; Adema GJ
ACS Nano; 2015 Jan; 9(1):733-45. PubMed ID: 25575241
[TBL] [Abstract][Full Text] [Related]
3. Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.
Macauley MS; Arlian BM; Rillahan CD; Pang PC; Bortell N; Marcondes MC; Haslam SM; Dell A; Paulson JC
J Biol Chem; 2014 Dec; 289(51):35149-58. PubMed ID: 25368325
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cells Regulate Sialylations of N-Glycans, Affecting Cell Migration and Survival.
Templeton K; Ramos M; Rose J; Le B; Zhou Q; Cressman A; Ferreyra S; Lebrilla CB; Fierro FA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206740
[TBL] [Abstract][Full Text] [Related]
5. Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells.
Chang WW; Yu CY; Lin TW; Wang PH; Tsai YC
Biochem Biophys Res Commun; 2006 Mar; 341(2):614-9. PubMed ID: 16427612
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Sialidase-Resistant Oligosaccharide and Antibody Glycoform Containing α2,6-Linked 3F
Lo HJ; Krasnova L; Dey S; Cheng T; Liu H; Tsai TI; Wu KB; Wu CY; Wong CH
J Am Chem Soc; 2019 Apr; 141(16):6484-6488. PubMed ID: 30969765
[TBL] [Abstract][Full Text] [Related]
7. Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.
Badr HA; AlSadek DM; Mathew MP; Li CZ; Djansugurova LB; Yarema KJ; Ahmed H
Biomaterials; 2015 Nov; 70():23-36. PubMed ID: 26295436
[TBL] [Abstract][Full Text] [Related]
8. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
9. A thin hydrogel barrier linked onto cell surface sialic acids through covalent bonds induces cancer cell death in vivo.
Ono K; Sanada Y; Kimura Y; Aoyama S; Ueda N; Katayama T; Nagahama K
Biomater Sci; 2020 Jan; 8(2):577-585. PubMed ID: 31872195
[TBL] [Abstract][Full Text] [Related]
10. Preferential lectin binding of cancer cells upon sialic acid treatment under nutrient deprivation.
Badr HA; Elsayed AI; Ahmed H; Dwek MV; Li CZ; Djansugurova LB
Appl Biochem Biotechnol; 2013 Oct; 171(4):963-74. PubMed ID: 23912210
[TBL] [Abstract][Full Text] [Related]
11. α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes.
Wang S; Chen X; Wei A; Yu X; Niang B; Zhang J
Tumour Biol; 2015 Feb; 36(2):885-92. PubMed ID: 25304155
[TBL] [Abstract][Full Text] [Related]
12. Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells.
Perdicchio M; Cornelissen LA; Streng-Ouwehand I; Engels S; Verstege MI; Boon L; Geerts D; van Kooyk Y; Unger WW
Oncotarget; 2016 Feb; 7(8):8771-82. PubMed ID: 26741508
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the α2,3-sialic acid residues in breast cancer is associated with metastatic potential.
Cui H; Lin Y; Yue L; Zhao X; Liu J
Oncol Rep; 2011 May; 25(5):1365-71. PubMed ID: 21344161
[TBL] [Abstract][Full Text] [Related]
14. Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2.
van den Bijgaart RJE; Kroesen M; Wassink M; Brok IC; Kers-Rebel ED; Boon L; Heise T; van Scherpenzeel M; Lefeber DJ; Boltje TJ; den Brok MH; Hoogerbrugge PM; Büll C; Adema GJ
J Biol Chem; 2019 Mar; 294(12):4437-4449. PubMed ID: 30670592
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
16. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
17. Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.
Wattanavises S; Silsirivanit A; Sawanyawisuth K; Cha'on U; Waraasawapati S; Saentaweesuk W; Luang S; Chalermwat C; Wongkham C; Wongkham S
Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31795149
[TBL] [Abstract][Full Text] [Related]
18. Towards understanding the role of sialylation in melanoma progression.
Kolasińska E; Przybyło M; Janik M; Lityńska A
Acta Biochim Pol; 2016; 63(3):533-41. PubMed ID: 27474400
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
Gnanapragassam VS; Bork K; Galuska CE; Galuska SP; Glanz D; Nagasundaram M; Bache M; Vordermark D; Kohla G; Kannicht C; Schauer R; Horstkorte R
PLoS One; 2014; 9(8):e105403. PubMed ID: 25148252
[TBL] [Abstract][Full Text] [Related]
20. Biochemical engineering of the acyl side chain of sialic acids stimulates integrin-dependent adhesion of HL60 cells to fibronectin.
Villavicencio-Lorini P; Laabs S; Danker K; Reutter W; Horstkorte R
J Mol Med (Berl); 2002 Oct; 80(10):671-7. PubMed ID: 12395152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
